Phase II study of asparagine-glycine-arginine-human tumor necrosis factor alpha, a selective vascular targeting agent, in previously treated patients with malignant pleural mesothelioma.
| Autor: | Gregorc V, Zucali PA, Santoro A, Ceresoli GL, Citterio G, De Pas TM, Zilembo N, De Vincenzo F, Simonelli M, Rossoni G, Spreafico A, Grazia Viganò M, Fontana F, De Braud FG, Bajetta E, Caligaris-Cappio F, Bruzzi P, Lambiase A, Bordignon C |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 5/20/2010, Vol. 28 Issue 15, p2604-2611, 8p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|